

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 8.44644491 |
| 2 | cellular response to nitric oxide (GO:0071732) | 7.99507042 |
| 3 | regulation of protein glycosylation (GO:0060049) | 7.46024201 |
| 4 | regulation of response to food (GO:0032095) | 7.00558390 |
| 5 | cellular response to leptin stimulus (GO:0044320) | 6.69187450 |
| 6 | response to leptin (GO:0044321) | 6.39754970 |
| 7 | cellular zinc ion homeostasis (GO:0006882) | 6.34878713 |
| 8 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 6.24717741 |
| 9 | sterol catabolic process (GO:0016127) | 6.02449665 |
| 10 | cholesterol catabolic process (GO:0006707) | 6.02449665 |
| 11 | cellular response to reactive nitrogen species (GO:1902170) | 5.82396518 |
| 12 | astrocyte development (GO:0014002) | 5.77158300 |
| 13 | interleukin-6-mediated signaling pathway (GO:0070102) | 5.63034551 |
| 14 | cellular response to cadmium ion (GO:0071276) | 5.58928246 |
| 15 | response to nitric oxide (GO:0071731) | 5.50533583 |
| 16 | negative regulation of necrotic cell death (GO:0060547) | 5.45303766 |
| 17 | zinc ion homeostasis (GO:0055069) | 5.32741773 |
| 18 | cellular response to oxygen radical (GO:0071450) | 4.93572609 |
| 19 | removal of superoxide radicals (GO:0019430) | 4.93572609 |
| 20 | cellular response to superoxide (GO:0071451) | 4.93572609 |
| 21 | glutamate secretion (GO:0014047) | 4.85187132 |
| 22 | neurofilament cytoskeleton organization (GO:0060052) | 4.46558677 |
| 23 | steroid catabolic process (GO:0006706) | 4.41084301 |
| 24 | synaptic vesicle exocytosis (GO:0016079) | 4.37450503 |
| 25 | activation of protein kinase B activity (GO:0032148) | 4.30727958 |
| 26 | galactose metabolic process (GO:0006012) | 4.20446586 |
| 27 | establishment of protein localization to Golgi (GO:0072600) | 4.13326489 |
| 28 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 4.12638319 |
| 29 | protein targeting to Golgi (GO:0000042) | 4.09850483 |
| 30 | negative regulation of appetite (GO:0032099) | 3.90822129 |
| 31 | negative regulation of response to food (GO:0032096) | 3.90822129 |
| 32 | response to superoxide (GO:0000303) | 3.82643031 |
| 33 | vitamin catabolic process (GO:0009111) | 3.79819693 |
| 34 | fat-soluble vitamin catabolic process (GO:0042363) | 3.79819693 |
| 35 | glial cell proliferation (GO:0014009) | 3.77799774 |
| 36 | galactose catabolic process (GO:0019388) | 3.74850685 |
| 37 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.73275007 |
| 38 | adaptation of signaling pathway (GO:0023058) | 3.70258274 |
| 39 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 3.67610936 |
| 40 | negative regulation of axon extension (GO:0030517) | 3.63507536 |
| 41 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.62758068 |
| 42 | urinary tract smooth muscle contraction (GO:0014848) | 3.54086060 |
| 43 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.53748394 |
| 44 | regulation of sensory perception (GO:0051931) | 3.46124222 |
| 45 | regulation of sensory perception of pain (GO:0051930) | 3.46124222 |
| 46 | behavioral fear response (GO:0001662) | 3.44389965 |
| 47 | behavioral defense response (GO:0002209) | 3.44389965 |
| 48 | response to oxygen radical (GO:0000305) | 3.44337609 |
| 49 | glutamate receptor signaling pathway (GO:0007215) | 3.41922090 |
| 50 | neuronal action potential (GO:0019228) | 3.38393984 |
| 51 | neuronal action potential propagation (GO:0019227) | 3.34618416 |
| 52 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.33749733 |
| 53 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.30621567 |
| 54 | zinc ion transport (GO:0006829) | 3.30204323 |
| 55 | cellular response to electrical stimulus (GO:0071257) | 3.27873442 |
| 56 | sleep (GO:0030431) | 3.27249257 |
| 57 | telomere maintenance via telomerase (GO:0007004) | 3.19358688 |
| 58 | ERK1 and ERK2 cascade (GO:0070371) | 3.16714600 |
| 59 | regulation of establishment of cell polarity (GO:2000114) | 3.14124355 |
| 60 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.11610281 |
| 61 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.11610281 |
| 62 | protein localization to synapse (GO:0035418) | 3.09100024 |
| 63 | detection of calcium ion (GO:0005513) | 3.06727514 |
| 64 | regulation of cell communication by electrical coupling (GO:0010649) | 3.06494737 |
| 65 | fear response (GO:0042596) | 3.05372716 |
| 66 | startle response (GO:0001964) | 3.02352004 |
| 67 | protein localization to Golgi apparatus (GO:0034067) | 2.97592089 |
| 68 | neurotransmitter secretion (GO:0007269) | 2.96001996 |
| 69 | negative regulation of oxidoreductase activity (GO:0051354) | 2.95592786 |
| 70 | synaptic transmission, glutamatergic (GO:0035249) | 2.95322923 |
| 71 | Golgi to plasma membrane protein transport (GO:0043001) | 2.92597653 |
| 72 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.91811519 |
| 73 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.88236600 |
| 74 | gamma-aminobutyric acid transport (GO:0015812) | 2.87898633 |
| 75 | protein-cofactor linkage (GO:0018065) | 2.87720779 |
| 76 | positive regulation of synapse maturation (GO:0090129) | 2.86407609 |
| 77 | positive regulation of potassium ion transport (GO:0043268) | 2.84567813 |
| 78 | magnesium ion transport (GO:0015693) | 2.83815484 |
| 79 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.83625606 |
| 80 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.83214445 |
| 81 | calcium ion-dependent exocytosis (GO:0017156) | 2.82959481 |
| 82 | protein import into nucleus, translocation (GO:0000060) | 2.82781504 |
| 83 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.78017222 |
| 84 | cellular anion homeostasis (GO:0030002) | 2.77940107 |
| 85 | relaxation of smooth muscle (GO:0044557) | 2.75482758 |
| 86 | regulation of mitochondrial depolarization (GO:0051900) | 2.74361989 |
| 87 | response to amphetamine (GO:0001975) | 2.72303175 |
| 88 | regulation of necrotic cell death (GO:0010939) | 2.69751068 |
| 89 | photoreceptor cell differentiation (GO:0046530) | 2.68811636 |
| 90 | eye photoreceptor cell differentiation (GO:0001754) | 2.68811636 |
| 91 | vitamin D metabolic process (GO:0042359) | 2.66986168 |
| 92 | behavioral response to cocaine (GO:0048148) | 2.65706486 |
| 93 | response to histamine (GO:0034776) | 2.62413608 |
| 94 | regulation of potassium ion transport (GO:0043266) | 2.62335430 |
| 95 | N-glycan processing (GO:0006491) | 2.60821617 |
| 96 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.60272270 |
| 97 | neuron-neuron synaptic transmission (GO:0007270) | 2.59917630 |
| 98 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.57309701 |
| 99 | single strand break repair (GO:0000012) | 2.56029267 |
| 100 | long-term synaptic potentiation (GO:0060291) | 2.52914873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.08357293 |
| 2 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.04868946 |
| 3 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.41229943 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.40704547 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.30212593 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.26341135 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 3.04816999 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.73844311 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.73276985 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.71563695 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.43411868 |
| 12 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.23593733 |
| 13 | P300_19829295_ChIP-Seq_ESCs_Human | 2.05795677 |
| 14 | FUS_26573619_Chip-Seq_HEK293_Human | 2.03809363 |
| 15 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.02158149 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.01723732 |
| 17 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.96585191 |
| 18 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.90604434 |
| 19 | EWS_26573619_Chip-Seq_HEK293_Human | 1.90224191 |
| 20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.87722261 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.82062116 |
| 22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.81639348 |
| 23 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.73586851 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.72674676 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.71846265 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.71683418 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.71211593 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.69799553 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67583254 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.63937324 |
| 31 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.63021934 |
| 32 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.62362388 |
| 33 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.57796939 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56947895 |
| 35 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.52996919 |
| 36 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.52626795 |
| 37 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.52626795 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.50335339 |
| 39 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47814346 |
| 40 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44400798 |
| 41 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43220681 |
| 42 | TCF4_23295773_ChIP-Seq_U87_Human | 1.42431741 |
| 43 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.41913046 |
| 44 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.41246453 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41079863 |
| 46 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.38759876 |
| 47 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.37211439 |
| 48 | STAT3_23295773_ChIP-Seq_U87_Human | 1.37076169 |
| 49 | AR_25329375_ChIP-Seq_VCAP_Human | 1.35773552 |
| 50 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.35763116 |
| 51 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35311375 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32814164 |
| 53 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.31856189 |
| 54 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.31168790 |
| 55 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.30620279 |
| 56 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.29669027 |
| 57 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.29525146 |
| 58 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.28286868 |
| 59 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.28259380 |
| 60 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.24600184 |
| 61 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.23890436 |
| 62 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22944501 |
| 63 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.22234810 |
| 64 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.19652102 |
| 65 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17939996 |
| 66 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.17592416 |
| 67 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17021425 |
| 68 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16741657 |
| 69 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.16589102 |
| 70 | JUN_21703547_ChIP-Seq_K562_Human | 1.16259321 |
| 71 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15887221 |
| 72 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15288362 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.15273828 |
| 74 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.15241989 |
| 75 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15144582 |
| 76 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.14467109 |
| 77 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.14346744 |
| 78 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.14346744 |
| 79 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.12770403 |
| 80 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.12722869 |
| 81 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11355981 |
| 82 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.10566061 |
| 83 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.10229678 |
| 84 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08673293 |
| 85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08673293 |
| 86 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08670180 |
| 87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07828684 |
| 88 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.07374422 |
| 89 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.06747068 |
| 90 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.05839361 |
| 91 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.05756292 |
| 92 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05010808 |
| 93 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.02666235 |
| 94 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01129001 |
| 95 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00888914 |
| 96 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00488944 |
| 97 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99330034 |
| 98 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98264666 |
| 99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95740829 |
| 100 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.94661009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008877_abnormal_DNA_methylation | 4.19057828 |
| 2 | MP0003787_abnormal_imprinting | 3.87415886 |
| 3 | MP0002064_seizures | 2.97511784 |
| 4 | MP0001968_abnormal_touch/_nociception | 2.96820443 |
| 5 | MP0009745_abnormal_behavioral_response | 2.90500045 |
| 6 | MP0004147_increased_porphyrin_level | 2.90091290 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 2.89727801 |
| 8 | MP0004043_abnormal_pH_regulation | 2.77034438 |
| 9 | MP0009046_muscle_twitch | 2.75427863 |
| 10 | MP0004885_abnormal_endolymph | 2.73464260 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.69762369 |
| 12 | MP0002272_abnormal_nervous_system | 2.63532368 |
| 13 | MP0005646_abnormal_pituitary_gland | 2.61573857 |
| 14 | MP0002736_abnormal_nociception_after | 2.61066464 |
| 15 | MP0001188_hyperpigmentation | 2.54264170 |
| 16 | MP0004859_abnormal_synaptic_plasticity | 2.45160797 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.35534535 |
| 18 | MP0003880_abnormal_central_pattern | 2.27428802 |
| 19 | MP0004270_analgesia | 2.03804201 |
| 20 | MP0001486_abnormal_startle_reflex | 2.03415680 |
| 21 | MP0002063_abnormal_learning/memory/cond | 2.01877586 |
| 22 | MP0005551_abnormal_eye_electrophysiolog | 2.00084302 |
| 23 | MP0001984_abnormal_olfaction | 1.91884933 |
| 24 | MP0002735_abnormal_chemical_nociception | 1.83414094 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.75293057 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 1.75159347 |
| 27 | MP0010386_abnormal_urinary_bladder | 1.70054241 |
| 28 | MP0006072_abnormal_retinal_apoptosis | 1.65907147 |
| 29 | MP0000569_abnormal_digit_pigmentation | 1.63659893 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.63021321 |
| 31 | MP0001905_abnormal_dopamine_level | 1.58222847 |
| 32 | MP0002089_abnormal_postnatal_growth/wei | 1.57312067 |
| 33 | MP0001764_abnormal_homeostasis | 1.56113060 |
| 34 | MP0001970_abnormal_pain_threshold | 1.49554493 |
| 35 | MP0002734_abnormal_mechanical_nocicepti | 1.43948298 |
| 36 | MP0001440_abnormal_grooming_behavior | 1.43183045 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.42099419 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 1.39572551 |
| 39 | MP0003121_genomic_imprinting | 1.39553148 |
| 40 | MP0001485_abnormal_pinna_reflex | 1.37187093 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.37022986 |
| 42 | MP0004742_abnormal_vestibular_system | 1.32851802 |
| 43 | MP0003633_abnormal_nervous_system | 1.28229736 |
| 44 | MP0001542_abnormal_bone_strength | 1.27895537 |
| 45 | MP0000955_abnormal_spinal_cord | 1.25526153 |
| 46 | MP0008875_abnormal_xenobiotic_pharmacok | 1.24956747 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.22631044 |
| 48 | MP0000631_abnormal_neuroendocrine_gland | 1.21133102 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.17351068 |
| 50 | MP0000604_amyloidosis | 1.17232170 |
| 51 | MP0008872_abnormal_physiological_respon | 1.17219887 |
| 52 | MP0001765_abnormal_ion_homeostasis | 1.13881768 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.11565482 |
| 54 | MP0004924_abnormal_behavior | 1.10576524 |
| 55 | MP0005386_behavior/neurological_phenoty | 1.10576524 |
| 56 | MP0008057_abnormal_DNA_replication | 1.08748315 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.07696613 |
| 58 | MP0001963_abnormal_hearing_physiology | 1.07496592 |
| 59 | MP0003631_nervous_system_phenotype | 1.06780943 |
| 60 | MP0005671_abnormal_response_to | 1.04339827 |
| 61 | MP0002557_abnormal_social/conspecific_i | 1.03003612 |
| 62 | MP0002882_abnormal_neuron_morphology | 1.03003565 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.01812742 |
| 64 | MP0003879_abnormal_hair_cell | 1.01164977 |
| 65 | MP0003122_maternal_imprinting | 1.00639535 |
| 66 | MP0003045_fibrosis | 1.00387619 |
| 67 | MP0005253_abnormal_eye_physiology | 0.99807035 |
| 68 | MP0002396_abnormal_hematopoietic_system | 0.99731015 |
| 69 | MP0002066_abnormal_motor_capabilities/c | 0.99691008 |
| 70 | MP0008995_early_reproductive_senescence | 0.98731217 |
| 71 | MP0003329_amyloid_beta_deposits | 0.97814301 |
| 72 | MP0005389_reproductive_system_phenotype | 0.97488588 |
| 73 | MP0002160_abnormal_reproductive_system | 0.95640531 |
| 74 | MP0003011_delayed_dark_adaptation | 0.93359479 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 0.92800846 |
| 76 | MP0002229_neurodegeneration | 0.91798282 |
| 77 | MP0001177_atelectasis | 0.89899119 |
| 78 | MP0002095_abnormal_skin_pigmentation | 0.89445927 |
| 79 | MP0000778_abnormal_nervous_system | 0.87283658 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 0.84501667 |
| 81 | MP0002752_abnormal_somatic_nervous | 0.82381295 |
| 82 | MP0006292_abnormal_olfactory_placode | 0.82262990 |
| 83 | MP0002184_abnormal_innervation | 0.80520353 |
| 84 | MP0008569_lethality_at_weaning | 0.79602726 |
| 85 | MP0000920_abnormal_myelination | 0.79391332 |
| 86 | MP0002909_abnormal_adrenal_gland | 0.76805471 |
| 87 | MP0003632_abnormal_nervous_system | 0.76695226 |
| 88 | MP0004134_abnormal_chest_morphology | 0.75492659 |
| 89 | MP0003690_abnormal_glial_cell | 0.75075895 |
| 90 | MP0008961_abnormal_basal_metabolism | 0.74150749 |
| 91 | MP0004133_heterotaxia | 0.73396543 |
| 92 | MP0000639_abnormal_adrenal_gland | 0.71821681 |
| 93 | MP0001851_eye_inflammation | 0.71592224 |
| 94 | MP0004142_abnormal_muscle_tone | 0.70162409 |
| 95 | MP0001919_abnormal_reproductive_system | 0.67400583 |
| 96 | MP0004215_abnormal_myocardial_fiber | 0.66141901 |
| 97 | MP0005376_homeostasis/metabolism_phenot | 0.64673320 |
| 98 | MP0004019_abnormal_vitamin_homeostasis | 0.64412796 |
| 99 | MP0000026_abnormal_inner_ear | 0.64122587 |
| 100 | MP0005535_abnormal_body_temperature | 0.63839905 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic hepatic failure (HP:0100626) | 6.36013795 |
| 2 | Atonic seizures (HP:0010819) | 5.16259691 |
| 3 | Volvulus (HP:0002580) | 5.15823529 |
| 4 | Focal seizures (HP:0007359) | 4.78873102 |
| 5 | Focal motor seizures (HP:0011153) | 4.69192727 |
| 6 | Action tremor (HP:0002345) | 4.13557370 |
| 7 | Pigmentary retinal degeneration (HP:0001146) | 3.97978174 |
| 8 | Absence seizures (HP:0002121) | 3.93082464 |
| 9 | Diplopia (HP:0000651) | 3.82440640 |
| 10 | Abnormality of binocular vision (HP:0011514) | 3.82440640 |
| 11 | Osteomalacia (HP:0002749) | 3.81012504 |
| 12 | Dialeptic seizures (HP:0011146) | 3.75936253 |
| 13 | Febrile seizures (HP:0002373) | 3.68497555 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.42948802 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.39913370 |
| 16 | Abnormality of renal resorption (HP:0011038) | 3.32862355 |
| 17 | Abnormality of midbrain morphology (HP:0002418) | 3.28969525 |
| 18 | Molar tooth sign on MRI (HP:0002419) | 3.28969525 |
| 19 | Epileptic encephalopathy (HP:0200134) | 3.14168905 |
| 20 | Gaze-evoked nystagmus (HP:0000640) | 3.10695345 |
| 21 | Progressive macrocephaly (HP:0004481) | 3.07988500 |
| 22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.00667851 |
| 23 | Pancreatic fibrosis (HP:0100732) | 2.99073794 |
| 24 | Hemiparesis (HP:0001269) | 2.96414425 |
| 25 | Ventricular fibrillation (HP:0001663) | 2.96335622 |
| 26 | Vascular calcification (HP:0004934) | 2.88251943 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 2.82353681 |
| 28 | Nephronophthisis (HP:0000090) | 2.75822968 |
| 29 | Acute encephalopathy (HP:0006846) | 2.74522039 |
| 30 | Limb dystonia (HP:0002451) | 2.64795509 |
| 31 | Myokymia (HP:0002411) | 2.60001594 |
| 32 | Medial flaring of the eyebrow (HP:0010747) | 2.51427905 |
| 33 | Nonprogressive disorder (HP:0003680) | 2.46645612 |
| 34 | Oligodactyly (hands) (HP:0001180) | 2.45318712 |
| 35 | Cardiovascular calcification (HP:0011915) | 2.43988159 |
| 36 | Spinal canal stenosis (HP:0003416) | 2.43416550 |
| 37 | Status epilepticus (HP:0002133) | 2.41787783 |
| 38 | Renal cortical cysts (HP:0000803) | 2.39646972 |
| 39 | Papilledema (HP:0001085) | 2.36640265 |
| 40 | Abnormality of the renal medulla (HP:0100957) | 2.34860603 |
| 41 | Epileptiform EEG discharges (HP:0011182) | 2.30690573 |
| 42 | Mitochondrial inheritance (HP:0001427) | 2.27680259 |
| 43 | Hyperphosphatemia (HP:0002905) | 2.26695144 |
| 44 | Congenital stationary night blindness (HP:0007642) | 2.25295596 |
| 45 | True hermaphroditism (HP:0010459) | 2.23286845 |
| 46 | Premature ovarian failure (HP:0008209) | 2.23040994 |
| 47 | Incomplete penetrance (HP:0003829) | 2.19681791 |
| 48 | Pancreatic cysts (HP:0001737) | 2.18352355 |
| 49 | Broad-based gait (HP:0002136) | 2.18340593 |
| 50 | Drooling (HP:0002307) | 2.15539024 |
| 51 | Dyskinesia (HP:0100660) | 2.14514215 |
| 52 | Hyperventilation (HP:0002883) | 2.14405001 |
| 53 | Leukodystrophy (HP:0002415) | 2.12828093 |
| 54 | Cerebral edema (HP:0002181) | 2.11508870 |
| 55 | Genetic anticipation (HP:0003743) | 2.07987045 |
| 56 | Sensory axonal neuropathy (HP:0003390) | 2.05672211 |
| 57 | Protruding tongue (HP:0010808) | 2.04224413 |
| 58 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.02224124 |
| 59 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.02224124 |
| 60 | Type 2 muscle fiber atrophy (HP:0003554) | 2.00937557 |
| 61 | Intention tremor (HP:0002080) | 1.99769846 |
| 62 | Excessive salivation (HP:0003781) | 1.98801230 |
| 63 | Specific learning disability (HP:0001328) | 1.98235945 |
| 64 | Gait imbalance (HP:0002141) | 1.97985694 |
| 65 | Postural instability (HP:0002172) | 1.96725117 |
| 66 | Ulnar claw (HP:0001178) | 1.96418803 |
| 67 | Nephrogenic diabetes insipidus (HP:0009806) | 1.96220140 |
| 68 | Congenital, generalized hypertrichosis (HP:0004540) | 1.92003841 |
| 69 | Abnormality of the renal cortex (HP:0011035) | 1.91999510 |
| 70 | Agnosia (HP:0010524) | 1.88776187 |
| 71 | Abolished electroretinogram (ERG) (HP:0000550) | 1.82820583 |
| 72 | Congenital primary aphakia (HP:0007707) | 1.82539812 |
| 73 | Generalized myoclonic seizures (HP:0002123) | 1.81692287 |
| 74 | Dysmetria (HP:0001310) | 1.80977289 |
| 75 | 3-Methylglutaconic aciduria (HP:0003535) | 1.79644461 |
| 76 | Truncal ataxia (HP:0002078) | 1.78888223 |
| 77 | Constricted visual fields (HP:0001133) | 1.78421036 |
| 78 | X-linked dominant inheritance (HP:0001423) | 1.76443407 |
| 79 | Optic disc pallor (HP:0000543) | 1.76248522 |
| 80 | Abnormal urine phosphate concentration (HP:0012599) | 1.75441668 |
| 81 | Abnormal eating behavior (HP:0100738) | 1.72866244 |
| 82 | Abnormality of renal excretion (HP:0011036) | 1.71472603 |
| 83 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.69507107 |
| 84 | Furrowed tongue (HP:0000221) | 1.68362009 |
| 85 | Hypochromic microcytic anemia (HP:0004840) | 1.68079926 |
| 86 | Lissencephaly (HP:0001339) | 1.67786377 |
| 87 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.67603228 |
| 88 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.67355342 |
| 89 | Inability to walk (HP:0002540) | 1.66915972 |
| 90 | Exotropia (HP:0000577) | 1.66522108 |
| 91 | Increased CSF lactate (HP:0002490) | 1.65720886 |
| 92 | Confusion (HP:0001289) | 1.65270220 |
| 93 | Dysdiadochokinesis (HP:0002075) | 1.64027007 |
| 94 | Prostate neoplasm (HP:0100787) | 1.63294668 |
| 95 | Abnormality of the prostate (HP:0008775) | 1.62527005 |
| 96 | Anxiety (HP:0000739) | 1.61013055 |
| 97 | EEG with generalized epileptiform discharges (HP:0011198) | 1.59836471 |
| 98 | Fair hair (HP:0002286) | 1.58584921 |
| 99 | Decreased central vision (HP:0007663) | 1.56950979 |
| 100 | Amblyopia (HP:0000646) | 1.56358231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 3.94170005 |
| 2 | PAK3 | 3.11579256 |
| 3 | MARK1 | 2.82782611 |
| 4 | TAOK3 | 2.63561824 |
| 5 | UHMK1 | 2.43070314 |
| 6 | NTRK3 | 2.28617502 |
| 7 | BMPR2 | 2.19878708 |
| 8 | MAP3K12 | 2.10865679 |
| 9 | FRK | 1.99688021 |
| 10 | PNCK | 1.98925674 |
| 11 | DMPK | 1.98920761 |
| 12 | PAK6 | 1.98529243 |
| 13 | CDC7 | 1.95601804 |
| 14 | MAP3K4 | 1.89055527 |
| 15 | PLK2 | 1.86455299 |
| 16 | MAP2K7 | 1.79636492 |
| 17 | SGK2 | 1.73804222 |
| 18 | DAPK2 | 1.72619442 |
| 19 | WNK3 | 1.67408946 |
| 20 | SGK223 | 1.63770145 |
| 21 | SGK494 | 1.63770145 |
| 22 | NTRK2 | 1.62715633 |
| 23 | TEC | 1.62508169 |
| 24 | CASK | 1.61499661 |
| 25 | STK39 | 1.61407522 |
| 26 | MAP3K9 | 1.49619081 |
| 27 | RIPK4 | 1.45662779 |
| 28 | CAMK2A | 1.42588881 |
| 29 | WNK4 | 1.38926312 |
| 30 | PRKCG | 1.38803275 |
| 31 | MINK1 | 1.37816114 |
| 32 | TRIM28 | 1.36500955 |
| 33 | TNIK | 1.31407822 |
| 34 | CAMK2B | 1.24523410 |
| 35 | MAPK13 | 1.22477940 |
| 36 | PTK2B | 1.15080596 |
| 37 | TSSK6 | 1.08938820 |
| 38 | MAP2K4 | 1.07574172 |
| 39 | CSNK1G2 | 1.04219373 |
| 40 | BUB1 | 1.02936250 |
| 41 | SGK1 | 1.00876990 |
| 42 | NUAK1 | 0.99375026 |
| 43 | CAMK1 | 0.95357197 |
| 44 | TXK | 0.94574679 |
| 45 | AKT3 | 0.93936098 |
| 46 | CAMK2G | 0.92141821 |
| 47 | CDK5 | 0.92007747 |
| 48 | MAP4K2 | 0.90446249 |
| 49 | ADRBK2 | 0.89228018 |
| 50 | STK16 | 0.87660662 |
| 51 | OXSR1 | 0.87267310 |
| 52 | SGK3 | 0.86624216 |
| 53 | GRK1 | 0.86369917 |
| 54 | CSNK1E | 0.86153593 |
| 55 | MST4 | 0.86142570 |
| 56 | CAMK2D | 0.85649587 |
| 57 | MAPKAPK3 | 0.84506481 |
| 58 | EPHA4 | 0.82724288 |
| 59 | PRKCQ | 0.78888922 |
| 60 | PIK3CA | 0.78625237 |
| 61 | DAPK1 | 0.78328768 |
| 62 | BRD4 | 0.77833981 |
| 63 | RPS6KA3 | 0.77197684 |
| 64 | CDK14 | 0.75964258 |
| 65 | TIE1 | 0.74676098 |
| 66 | CSNK1G3 | 0.73007831 |
| 67 | INSRR | 0.72764130 |
| 68 | IRAK2 | 0.71213387 |
| 69 | CDK11A | 0.66962866 |
| 70 | PRKG1 | 0.66266227 |
| 71 | CCNB1 | 0.64594295 |
| 72 | ERBB3 | 0.61852680 |
| 73 | CDK18 | 0.61703290 |
| 74 | MAPK15 | 0.60921969 |
| 75 | CDK3 | 0.60370038 |
| 76 | CDK15 | 0.59115737 |
| 77 | CSNK1G1 | 0.57901060 |
| 78 | CSNK1A1 | 0.57363627 |
| 79 | FES | 0.57027980 |
| 80 | PRKACA | 0.56915012 |
| 81 | PRKACB | 0.54941602 |
| 82 | CSNK1A1L | 0.54591108 |
| 83 | PRKCH | 0.52987772 |
| 84 | SYK | 0.52523019 |
| 85 | PLK4 | 0.52512760 |
| 86 | TNK2 | 0.51045857 |
| 87 | GRK5 | 0.49616756 |
| 88 | PRKCA | 0.48132022 |
| 89 | MAPK10 | 0.47262761 |
| 90 | BMPR1B | 0.46940777 |
| 91 | PHKG1 | 0.41498682 |
| 92 | PHKG2 | 0.41498682 |
| 93 | CSNK1D | 0.41243652 |
| 94 | PRKCE | 0.38768337 |
| 95 | KIT | 0.38744508 |
| 96 | DYRK1A | 0.36817885 |
| 97 | GSK3B | 0.36452405 |
| 98 | CSNK2A2 | 0.35493933 |
| 99 | PRKCZ | 0.35229410 |
| 100 | MAPK14 | 0.35182033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.98294985 |
| 2 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.58689142 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.47374849 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.41092370 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.36937576 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.36381109 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.33302378 |
| 8 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.31929843 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.31544424 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.16715233 |
| 11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.12746547 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.06136717 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 2.03559885 |
| 14 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 2.03272960 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 2.02100682 |
| 16 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.00267195 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.96848945 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.93520704 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.93388130 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.86726560 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.85635898 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.68732362 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.65131548 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54693748 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50620962 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.43664202 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.43098205 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.41772093 |
| 29 | Olfactory transduction_Homo sapiens_hsa04740 | 1.36533856 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.35900759 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.35715128 |
| 32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.32969318 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.28067620 |
| 34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.26803367 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.23991026 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21088677 |
| 37 | Homologous recombination_Homo sapiens_hsa03440 | 1.20810588 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.15345273 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15195611 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.07495532 |
| 41 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05003735 |
| 42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.02772044 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99868836 |
| 44 | Mineral absorption_Homo sapiens_hsa04978 | 0.98146099 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91360730 |
| 46 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.89264679 |
| 47 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.86879614 |
| 48 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.83985223 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81618614 |
| 50 | Long-term depression_Homo sapiens_hsa04730 | 0.81591957 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81504879 |
| 52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81009882 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78472419 |
| 54 | Basal transcription factors_Homo sapiens_hsa03022 | 0.77697823 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75981854 |
| 56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72383073 |
| 57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71201237 |
| 58 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69466807 |
| 59 | Allograft rejection_Homo sapiens_hsa05330 | 0.68816522 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63178345 |
| 61 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63108126 |
| 62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62863763 |
| 63 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62427062 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61457379 |
| 65 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.59810344 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59067791 |
| 67 | Huntingtons disease_Homo sapiens_hsa05016 | 0.58710457 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55014004 |
| 69 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54167736 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53796089 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53731979 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51374711 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45199135 |
| 74 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45121489 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43993340 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.43513256 |
| 77 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43489385 |
| 78 | RNA degradation_Homo sapiens_hsa03018 | 0.42781980 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42033820 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.41149322 |
| 81 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.39982778 |
| 82 | RNA polymerase_Homo sapiens_hsa03020 | 0.39583344 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.38671977 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37760367 |
| 85 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36171781 |
| 86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.35353308 |
| 87 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.34944296 |
| 88 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33800404 |
| 89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31507053 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29753084 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.27878362 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.27412588 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.25184552 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.24385515 |
| 95 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.24188930 |
| 96 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.23927462 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23240840 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.21124665 |
| 99 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.20243985 |
| 100 | Gap junction_Homo sapiens_hsa04540 | 0.19510483 |

